Bandingkan Harga & Kinerja Aviana Sinar Abadi Tbk. (IRSX) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Aviana Sinar Abadi Tbk. dan Organon Pharma Indonesia Tbk.: Aviana Sinar Abadi Tbk. diperdagangkan di Rp414 (kapitalisasi pasar 2,53 T, volume 24 jam 36,64 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Aviana Sinar Abadi Tbk. jauh lebih besar — sekitar 24,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| IRSX | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 2,53 T | 104,4 M |
Volume | 36,64 jt | — |
Lot | 366,44 rb | — |
Perputaran | 14,84 M | — |
Harga Rata-rata | 405,07 | — |
Nilai Transaksi | 14,84 M | — |
Harga Ekuilibrium Indikatif | 414 | — |
Volume Ekuilibrium Indikatif | 8,28 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Aviana Sinar Abadi Tbk.
PT Aviana Sinar Abadi Tbk (the Company) was established on December 17, 2013 based on Notarial Deed No. 15 of Isadora, S.H., M.Kn., notary in Jakarta. The Company started its commercial operations in 2013.
Selengkapnya di halaman IRSX →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
